Annals of the New York Academy of Sciences

publication venue for

Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibody. 1993
Viral immunity: Basic mechanisms and therapeutic applications-a Keystone Symposia report. 2023
Organoids as tools for fundamental discovery and translation-a Keystone Symposia report.. 1518. 2022
Interventions to increase adherence to micronutrient supplementation during pregnancy: a systematic review.. 1493. 2021
Changes in DNA methylation accompany changes in gene expression during chondrocyte hypertrophic differentiation in vitro.. 1490. 2020
Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review.. 1484. 2020
Interventions to increase adherence to micronutrient supplementation during pregnancy: a protocol for a systematic review.. 1470. 2020
Setting research priorities on multiple micronutrient supplementation in pregnancy.. 1465. 2019
CITED2 mediates the cross-talk between mechanical loading and IL-4 to promote chondroprotection.. 1442. 2019
CITED2 mediates the mechanical loading-induced suppression of adipokines in the infrapatellar fat pad.. 1442. 2019
Linking the degree of virilization in females with congenital adrenal hyperplasia to genotype.. 1402. 2017
EEG biomarkers of target engagement, therapeutic effect, and disease process.. 1344. 2015
Hypertonic saline for the management of raised intracranial pressure after severe traumatic brain injury.. 1345. 2015
New strategies and findings for behavioral interventions in autism spectrum disorders.. 1304. 2013
The thinking ape: the enigma of human consciousness.. 1303. 2013
The future of tic disorder treatment.. 1304. 2013
Risk for anxiety and implications for treatment: developmental, environmental, and genetic factors governing fear regulation.. 1304. 2013
Meditation improves self-regulation over the life span.. 1307. 2013
Challenges to deep brain stimulation: a pragmatic response to ethical, fiscal, and regulatory concerns.. 1265. 2012
Barrett's esophagus: clinical features, obesity, and imaging.. 1232. 2011
Barrett's esophagus: treatments of adenocarcinomas II.. 1232. 2011
Esophageal stem cells and 3D-cell culture models.. 1232. 2011
Sociophysiology 25 years ago: early perspectives of an emerging discipline now part of social neuroscience.. 1231. 2011
Behavioral epigenetics.. 1226. 2011
Development and early evaluation of the Virtual Iraq/Afghanistan exposure therapy system for combat-related PTSD.. 1208. 2010
House calls revisited: leveraging technology to overcome obstacles to veteran psychiatric care and improve treatment outcomes.. 1208. 2010
Improvement in cerebral function with treatment of posttraumatic stress disorder.. 1208. 2010
Monitoring mental health treatment acceptance and initial treatment adherence in veterans: veterans of Operations Enduring Freedom and Iraqi Freedom versus other veterans of other eras.. 1208. 2010
Responding to infection and apoptosis--a task for TH17 cells.. 1209. 2010
Using biological markers to inform a clinically meaningful treatment response.. 1208. 2010
Virtual reality exposure therapy for combat-related posttraumatic stress disorder.. 1208. 2010
A preclinical approach for gene therapy of beta-thalassemia.. 1202. 2010
Combined iron chelation therapy.. 1202. 2010
Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron.. 1202. 2010
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia.. 1202. 2010
The involvement of ZnT-1, a new modulator of cardiac L-type calcium channels, in [corrected] atrial tachycardia remodeling. [corrected].. 1188. 2010
Dysregulation of the vitamin D nuclear receptor may contribute to the higher prevalence of some autoimmune diseases in women.. 1173. 2009
Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease.. 1173. 2009
Vitamin D metabolites as clinical markers in autoimmune and chronic disease.. 1173. 2009
Tibetan medicine: a complementary science of optimal health.. 1172. 2009
Information processing in the parabrachial nucleus of the pons.. 1170. 2009
Bartonella endocarditis: a pathology shared by animal reservoirsand patients.. 1166. 2009
HLA class I supertypes in type 1 diabetic children in an urban children's hospital.. 1150. 2008
Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injury.. 1147. 2008
Orthopedic implant particle-induced tumor necrosis factor-alpha production in macrophage-monocyte lineage cells is mediated by nuclear factor of activated T cells.. 1117. 2007
Perfusion abnormalities in subchondral bone associated with marrow edema, osteoarthritis, and avascular necrosis.. 1117. 2007
Structural and functional genetic disorders of the great vessels and outflow tracts.. 1085. 2006
Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.. 1075. 2006
Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes.. 1062. 2005
Overcoming barriers to the transformation of the genus Ehrlichia.. 1063. 2005
TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.. 1062. 2005
Genetic targeting of relaxin and insl3 signaling in mice.. 1041. 2005
Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia.. 1054. 2005
Methods for noninvasive measurement of tissue iron in Cooley's anemia.. 1054. 2005
Clinical proteomics and biomarker discovery.. 1022. 2004
Potential role of recombinant annexin II in diabetic vascular injury.. 947. 2001
The MORE trial: multiple outcomes for raloxifene evaluation--breast cancer as a secondary end point: implications for prevention.. 949. 2001
Construction of recombinant adenoviral vector of annexin II.. 902. 2000
Binswanger disease: the history of a silent epidemic.. 903. 2000
Plasma beta-amyloid peptide, transforming growth factor-beta 1, and risk for cerebral amyloid angiopathy.. 903. 2000
Expression of inflammatory cytokines in a mouse transformed Clara cell line by tumor necrosis factor-alpha.. 923. 2000
beta-Endorphin binding and regulation of cytokine expression in Langerhans cells.. 885. 1999
Wnt signaling stabilizes the dual-function protein beta-catenin in diverse cell types.. 857. 1998
Bone marrow transplantation for homozygous beta-thalassemia. The Memorial Sloan-Kettering Cancer Center experience.. 850. 1998
Future orientation and life expectations of adolescents and young adults with thalassemia major.. 850. 1998
Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience.. 850. 1998
A mouse model of transplacental cocaine exposure. Clinical implications for exposed infants and children.. 846. 1998
A Mouse Model of Transplacental Cocaine Exposure: Clinical Implications for Exposed Infants and Children^a.. 846. 1998
Introduction.. 846. 1998
Preface.. 846. 1998
Round Table 1. Drug Interactions in Cocaine Abuse: Methodologic Concerns in Human and Animal Studies.. 846. 1998
Round Table 2. Consensus on Postnatal Deficits: Comparability of Human and Animal Findings.. 846. 1998
Round Table 4. Levels of Vulnerability in Functional Deficits: Specificity of Dysfunctional Brain Systems.. 846. 1998
Cyclooxygenase-2 gene expression is upregulated in transformed mammary epithelial cells.. 833. 1997
Sensory coding in cortical neurons. Recent results and speculations.. 835. 1997
Importance of vascular changes in selective neurodegeneration with thiamine deficiency.. 826. 1997
Identification of dysfunctional endothelial cells over vascular lesions in the non-human primate.. 811. 1997
Truth, science, and the oncologist.. 809. 1997
Aortic aneurysmal disease in women. Is there a greater incidence of suprarenal involvement?. 800. 1996
A novel ets-2-related nuclear factor is involved in transcriptional activation of the human interleukin-12 p40 gene promoter in response to interferon-gamma and LPS stimulation of monocytic cells.. 795. 1996
Regulation by interleukin-10 of Staphylococcus aureus- and lipopolysaccharide-induced interleukin-12 gene expression in human peripheral blood mononuclear cells.. 795. 1996
Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease.. 770. 1995
Target detection and the prefrontal cortex. A PET scan study of the P300 event-related potential.. 769. 1995
A case-series study of p53 nuclear overexpression in early-stage stomach cancer.. 768. 1995
Head and neck screening day for the community.. 768. 1995
Investigation of the possible role of WNT genes in human breast cancer.. 768. 1995
Analysis of immunoglobulin gamma heavy chains from rheumatoid arthritis synovium. Evidence of antigen-driven selection.. 764. 1995
Cellular origin, antigen reactivity, and VH segment structure of IgM mAbs from AIDS lymphomas.. 764. 1995
Characterization and genomic mapping of a novel leader peptide associated with the human VH4-21 (VH4-34) gene segment.. 764. 1995
Clonal analysis of IgM+ CD5+ CLL B cells.. 764. 1995
Distribution of imidazoline receptor binding protein in the central nervous system.. 763. 1995
Characterization of oligoclonal synovial T-cells in rheumatoid arthritis.. 756. 1995
Antiganglioside antibodies in patients with acute polio and post-polio syndrome.. 753. 1995
Phospholipase signalling pathways in thyroxine-induced cardiac hypertrophy.. 752. 1995
Defining social choices and distributing social resources on the health care commons.. 729. 1994
Alpha 2-macroglobulin/transforming growth factor-beta 1 interactions. Modulation by heparin-like molecules and effects on vascular smooth muscle cells.. 737. 1994
Leukotriene generation and pulmonary dysfunction following aortic cross clamp in humans.. 723. 1994
Effects of toxins on Ca2+ currents and peptide release from nerve terminals.. 710. 1994
Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report.. 698. 1993
Altered immune function in a morbidly obese pediatric population.. 699. 1993
Human muscle acetylcholine receptor reactive T and B lymphocytes in myasthenia gravis.. 681. 1993
Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.. 651. 1992
Role of T cell activation in the pathogenesis of psoriasis.. 636. 1991
Mechanism of herpesviral entry into cells. Role of fibroblast growth factor receptor.. 638. 1991
The effect of low-energy combined AC and DC magnetic fields on articular cartilage metabolism.. 635. 1991
Workshop summary: negative regulation of macrophage effector function.. 628. 1991
Site-directed mutagenesis applied to glucose isomerase from Streptomyces violaceoniger and Streptomyces olivochromogenes.. 613. 1990
The regulation of the expression of genes encoding basement membrane proteins during the retinoic acid-associated differentiation of murine teratocarcinoma cells.. 580. 1990
Changes in calcium homeostasis during aging and Alzheimer's disease.. 568. 1989
Antibodies to sulfated glucuronic acid containing glycosphingolipids in neuropathy associated with anti-MAG antibodies and in normal individuals.. 540. 1988
Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer.. 547. 1988
Dopamine, acetylcholine, and glutamate interactions in aging. Behavioral and neurochemical correlates.. 515. 1988
Generation of antibodies to gangliosides GM1 and GD1b. Genetic control of fine antigenic specificity.. 540. 1988
Intracellular messengers. Influence of oligodendrocyte substratum adhesion.. 540. 1988
Oocyte donation. The Norfolk Program.. 541. 1988
The ovarian prorenin-angiotensin system. Lessons from IVF.. 541. 1988
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes.. 540. 1988
Arrangements and rearrangements of the human T-cell receptor gamma gene.. 511. 1987
Retroviral vector-mediated gene transfer and expression in nonhuman primates following autologous bone marrow transplantation.. 511. 1987
The role of residual host immunity in graft failures following T-cell-depleted marrow transplants for leukemia.. 511. 1987
Calcium and calmodulin in the regulation of the microtubular cytoskeleton.. 466. 1986
Neuroendocrine studies in depression. Relationship to suicidal behavior.. 487. 1986
Personality and suicide.. 487. 1986
Postmortem monoamine receptor and enzyme studies in suicide.. 487. 1986
Studies of amine metabolites in depressed patients. Relationship to suicidal behavior.. 487. 1986
Suicide prevention. Current efficacy and future promise.. 487. 1986
Surface charges near the guanidinium neurotoxin binding site.. 479. 1986
Surface immunoglobulin light chain expression in pre-B cell leukemias.. 468. 1986
A psychosocial needs assessment of patients with homozygous beta-thalassemia.. 445. 1985
Glucose transport in a model of the rat proximal tubule epithelium.. 456. 1985
Monoclonal antibodies to desmin: evidence for stage-dependent intermediate filament immunoreactivity during cardiac and skeletal muscle development.. 455. 1985
Specific effects of FSH and LH on follicular development and oocyte retrieval as determined by a program for in vitro fertilization.. 442. 1985
The effect of subcutaneous deferoxamine on the cardiac profile of thalassemia major: a five-year study.. 445. 1985
Topology of the lac permease protein in the membrane of Escherichia coli.. 456. 1985
A multifactorial model for the development of AIDS in homosexual men.. 437. 1984
Autoantibodies to T cells in adult and pediatric AIDS.. 437. 1984
Detection of spontaneously occurring sperm-directed antibodies in infertile couples by immunobead binding and enzyme-linked immunosorbent assay.. 438. 1984
Generalized lymphadenopathy in homosexual men: an update of the New York experience.. 437. 1984
Inhibition of lymphocyte proliferation by sera from rectally inseminated male rabbits.. 437. 1984
Recombinant leukocyte A interferon in Kaposi's sarcoma.. 437. 1984
Soluble factors inhibitory for T-cell-dependent immune responses in patients with the acquired immune deficiency syndrome and its prodromes.. 437. 1984
Acidification of endocytic vesicles and the intracellular pathways of ligands and receptors.. 421. 1983
Autologous bone marrow transplantation using unfractionated cells without rate-controlled freezing in hydroxyethyl starch and dimethyl sulfoxide.. 411. 1983
Toxicology and antitumor activity of tuftsin.. 419. 1983
Arachidonic acid metabolism in endothelial cells and platelets.. 401. 1982
Effects of click polarity on brainstem auditory evoked potentials in normal subjects and patients: unexpected sensitivity of wave V.. 388. 1982
Metabolic factors as mediators of pulmonary vascular injury.. 384. 1982
Studies of beta-endorphin in psychiatric patients.. 398. 1982
beta-Endorphin immunoreactivity in the plasma of psychiatric patients receiving electroconvulsive treatment.. 398. 1982
Control of apical sodium permeability in the toad urinary bladder by aldosterone.. 372. 1981
Models for active sites of metalloenzymes. II. Interactions with a model substrate.. 367. 1981
Quantum chemical studies on molecular determinants for drug action.. 367. 1981
The effects of carbamylcholine, calcium, and cyclic nucleotides on acetylcholine receptor synthesis in cultured myotubes.. 377. 1981
Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II.. 348. 1980
Dynamics of lipid motions in high-density lipoprotein subfractions HDL2 and HDL3: magnetic resonance studies.. 348. 1980
Psychiatry on trial: clinical and ethical problems in the psychiatric assessment of competency to stand trial.. 347. 1980
The origin and structure of endogenous retroviral DNA.. 354. 1980
Serotonin involvement in pituitary-adrenal function.. 297. 1977
Correlation of clinical and virus-specific immune responses following levamisole therapy of recurrent herpes progenitalis.. 284. 1977
A psychiatrist looks at scientists looking at science.. 265. 1976
An immunologically induced defect of neuromuscular transmission in rats and rabbits.. 274. 1976
Delayed cutaneous hypersensitivity reactions and prognosis in patients with cancer.. 276. 1976
Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles.. 274. 1976
Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma.. 277. 1976
Effect of lead and genetic factors on heme biosynthesis in the human red cell.. 244. 1975
The role of autolysins in cell death.. 235. 1974
Trophic functions of the neuron. IV. Clinical disorders of trophic functions muscular dystrophy? Sick motoneurons and muscle disease.. 228. 1974
Endocrine function in thalassemia major.. 232. 1974
On the mechanism of sodium movement across epithelia.. 204. 1973
Drug-induced alterations of steroid hormone metabolism in man.. 212. 1973
The platelet as an inflammatory cell.. 201. 1972
Abnormal steroid hormone metabolism in the genetic liver disease acute intermittent porphyria.. 179. 1971
Serious infections caused by diphtheroids.. 174. 1970
5'-nucleotidase of plasma membranes of the rat liver: studies on subcellular distribution.. 166. 1969
Experimental hepatic porphyria: studies with steroids of physiological origin in man.. 151. 1968
TISSUE CULTURE STUDIES OF DEMYELINATION.. 122. 1965
Brain stimulation in neurology and psychiatry: perspectives on an evolving field.. 1265. 2012
Introduction to high-pressure bioscience and biotechnology.. 1189. 2010
Disorders of consciousness. Preface.. 1157. 2009
Mitochondria and oxidative stress in neurodegenerative disorders. Preface.. 1147. 2008
Breaking ground on translational stem cell research. 2010
Mitochondrial dysfunction and potential mitochondrial protectant treatments in tendinopathy. 2021
Phenotypic instability of chondrocytes in osteoarthritis: on a path to hypertrophy. 2018
The role of autophagy in the regulation of yeast life span. 2018
Tissue-specific endothelial cells: a promising approach for augmentation of soft tissue repair in orthopedics. 2017
Bipolar disorders in the Arab world: a critical review. 2015
Mechanistic insights into antibiotic action on the ribosome through single-molecule fluorescence imaging. 2011
Weak links: Advancing target-based drug discovery by identifying the most vulnerable targets. 2024
Noncoding RNAs: biology and applications-a Keystone Symposia report. 2021
Frontiers in cancer immunotherapy-a symposium report. 2020
Presence of Ebola virus in breast milk and risk of mother-to-child transmission: synthesis of evidence. 2020
Leveraging insights into cancer metabolism-a symposium report. 2019
Vaccine innovations for emerging infectious diseases-a symposium report. 2019
Adult stem cells and regenerative medicine-a symposium report. 2019
Inflammatory biomarkers of low back pain and disc degeneration: a review. 2017
The deeper self: an expanded view of consciousness. 2017
The subtle body: an interoceptive map of central nervous system function and meditative mind-brain-body integration. 2016
Vitamin B1 (thiamine) and dementia. 2016
Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach. 2016
Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease). 2016
Perspectives on depression--past, present, future(a). 2015
Designing optogenetically controlled RNA for regulating biological systems. 2015
Meditation research, past, present, and future: perspectives from the Nalanda contemplative science tradition. 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma. 2013
Moving toward a generalizable application of central thalamic deep brain stimulation for support of forebrain arousal regulation in the severely injured brain. 2012
Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system. 2011
New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation. 2011
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? 2010
Hepcidin and Hfe in iron overload in beta-thalassemia. 2010
Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. 2010
Noninvasive methods of measuring bone blood perfusion. 2010
Optimizing learning and quality of life throughout the lifespan: a global framework for research and application. 2009
Being conscious of their burden: severe brain injury and the two cultures challenge. 2009
Central thalamic deep-brain stimulation in the severely injured brain: rationale and proposed mechanisms of action. 2009
5alpha-reductase isozymes and androgen actions in the prostate. 2009
Progress in the understanding of the genetic etiology of vertebral segmentation disorders in humans. 2009
Oxidant-induced changes in mitochondria and calcium dynamics in the pathophysiology of Alzheimer's disease. 2008
The adolescent brain. 2008
Central thalamic contributions to arousal regulation and neurological disorders of consciousness. 2008
NUP98 dysregulation in myeloid leukemogenesis. 2007
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease. 2007
Neuroendocrine regulation of skin dendritic cells. 2006
Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis. 2005
Progress toward the genetic treatment of the beta-thalassemias. 2005
Role of mitochondria in oxidative stress and aging. 2002
Annexin II and regulation of cell surface fibrinolysis. 2000
Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. 2000
Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. 2000
Physiological regulation of uteroglobin/CCSP expression. 2000
Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits. 1999
Neural precursors and neuronal production in the adult mammalian forebrain. 1997
Annexin II: a novel mediator of cell surface plasmin generation. 1997
Regulation of interleukin-12 production. 1996
Cell growth signal transduction is quantal. 1995
Neurodegenerative disease: autoimmunity involving calcium channels. 1994
Use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease. 1994
Adenovirus-mediated in vivo gene transfer. 1994
High-intensity chemotherapy with hematopoietic support in breast cancer. 1993
Kinetic concepts in the treatment of breast cancer. 1993
Reservoirs of HIV infection or carriage: monocytic, dendritic, follicular dendritic, and B cells. 1993
Neural transplantation for neurodegenerative diseases: past, present, and future. 1993
Recognition of autoantigens by patients with melanoma. 1993
Anti-idiotypic immunity as a potential regulator in myeloma and related diseases. 1991
Endothelial cell fibrinolytic assembly. 1991
Current therapy of Cooley's anemia. A decade of experience with subcutaneous desferrioxamine. 1990
Mechanisms of matrix degradation in rheumatoid arthritis. 1990
Treatment strategies for cryptosporidiosis. 1990
Elementary aspects of acid-base permeation and pH regulation. 1989
Calcium antagonist receptors. Clinical and physiological relevance. 1988
Mechanisms of action of CRF and other regulators of ACTH release in pituitary corticotrophs. 1987
Levamisole and inosiplex: antiviral agents with immunopotentiating action. 1977
Serum acetylcholine-receptor antibodies in myasthenia gravis. 1976
Inhibition of complement-derived enzymes. 1975
Impaired defense mechanisms associated with acute alcoholism. 1975

VIVO Weill Cornell Medical College

Annals of the New York Academy of Sciences Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)